{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:30:17Z","timestamp":1761845417464},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Plurihormonal pituitary adenomas are a unique type of pituitary adenomas that secrete two or more pituitary hormones normally associated with separate cell types that have different immunocytochemical and ultrastructural features. Although they represent 10\u201315% of all pituitary tumors, only a small fraction of plurihormonal pituitary adenomas clinically secrete multiple hormones. The most common hormone combinations secreted by plurihormonal pituitary adenomas are growth hormone, prolactin, and one or more glycoprotein hormones. The most common hormonal symptom is acromegaly (50%). The aim of this case report is to bring awareness about this rare type of pituitary adenomas and to describe the unique presentation of our patient, even though plurihormonal pituitary adenomas are known mostly as a clinically silent tumors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Herein, we describe an unusual case of plurihormonal pituitary adenoma with triple-positive staining for adrenocorticotropic hormone, growth hormone, and prolactin. The patient is a 65-year-old Egyptian woman who presented with mass effect symptoms of the pituitary tumor, which primarily manifested as severe headache and visual field defects. She also presented with some cushingoid features, and further analysis confirmed Cushing\u2019s disease; slightly high prolactin and normal growth hormone levels were observed. She underwent transsphenoidal surgery and has been in remission thus far. Only a few cases have been reported in the literature, but none has exhibited silent acromegaly or mass effect symptoms as the initial presentation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case highlights an unusual plurihormonal pituitary adenoma case with a rare combination of secreted hormones; mass effect symptoms were dominant, as were uncommon visual field defects. Our case further proves that immunohistochemical analyses of all pituitary hormones are needed to ensure correct diagnosis and to alert clinicians to the need for more rigorous follow-up due to the higher morbidity of these patients. Our case report approval number Federal Wide Assurance NIH, USA is FWA00018774 IRB registration number with OHRP\/NIH is IRB00010471.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-02948-6","type":"journal-article","created":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:05:12Z","timestamp":1627513512000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Plurihormonal pituitary macroadenoma:\u00a0 a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Ebtesam","family":"Allehaibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mussa H.","family":"AlMalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad","family":"Brema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"2948_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/1043-2760(89)90012-X","volume":"1","author":"K Kovaks","year":"1989","unstructured":"Kovaks K, Horvath E, Asa SL, Stefaneanu L, Sano T. Pituitary cells producing more than one hormone human pituitary adenomas. Trends Endocrinol Metab. 1989;1:104\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"2948_CR2","volume-title":"Classification of tumours of endocrine organs","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Classification of tumours of endocrine organs. 4th ed. Geneva: World Health Organization; 2017.","edition":"4"},{"key":"2948_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017;28:228\u201343.","journal-title":"Endocr Pathol"},{"issue":"2","key":"2948_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10014-018-0314-3","volume":"35","author":"N Inoshita","year":"2018","unstructured":"Inoshita N, Nishioka H. The 2017 WHO classification of pituitary adenoma: overview and comments. Brain Tumor Pathol. 2018;35(2):51\u20136.","journal-title":"Brain Tumor Pathol"},{"issue":"3","key":"2948_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00418-008-0472-1","volume":"130","author":"RY Osamura","year":"2008","unstructured":"Osamura RY, Kajiya H, Takei M, et\u00a0al. Pathology of the human pituitary adenomas. Histochem Cell Biol. 2008;130(3):495\u2013507.","journal-title":"Histochem Cell Biol"},{"key":"2948_CR6","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1210\/jc.2013-4376","volume":"99","author":"E Malchiodi","year":"2014","unstructured":"Malchiodi E, Profka E, Ferrante E, Sala E, Verrua E, Campi I, Lania AG, Arosio M, Locatelli M, Mortini P, et\u00a0al. Thyrotropin-secreting pituitary adenomas: outcome of pituitary surgery and irradiation. J Clin Endocrinol Metab. 2014;99:2069\u201376.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2948_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3171\/2008.8.JNS08154","volume":"110","author":"K Oki","year":"2009","unstructured":"Oki K, Yamane K, Oda Y, et\u00a0al. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone: case report. J Neurosurg. 2009;110(2):369\u201373.","journal-title":"J Neurosurg"},{"key":"2948_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/529730","author":"S Kannan","year":"2012","unstructured":"Kannan S, Staugaitis SM, Weil RJ, et\u00a0al. Case report: a rare corticotroph-secreting tumor with coexisting prolactin and growth hormone staining cells. Case Rep Endocrinol. 2012. https:\/\/doi.org\/10.1155\/2012\/529730.","journal-title":"Case Rep Endocrinol"},{"issue":"10","key":"2948_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1097\/01.MP.0000030451.28828.00","volume":"15","author":"S Tahara","year":"2002","unstructured":"Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Osamura RY. A case of Cushing\u2019s disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol. 2002;15(10):1102\u20135.","journal-title":"Mod Pathol"},{"issue":"5","key":"2948_CR10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1507\/endocrj.K06-031","volume":"53","author":"K Tsuchiya","year":"2006","unstructured":"Tsuchiya K, Ohta K, Yoshimoto T, Dai M, Izumiyama H, Hirata Y. A case of acromegaly associated with subclinical Cushing\u2019s disease. Endocr J. 2006;53(5):679\u201385.","journal-title":"Endocr J"},{"key":"2948_CR11","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/j.wneu.2018.02.120","volume":"114","author":"E Roca","year":"2018","unstructured":"Roca E, Mattogno PP, Porcelli T, et\u00a0al. Plurihormonal ACTH\u2013GH pituitary adenoma: case, report and systematic literature review. World Neurosurg. 2018;114:e158\u201364.","journal-title":"World Neurosurg."},{"key":"2948_CR12","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2015.389","author":"H Korkmaz","year":"2015","unstructured":"Korkmaz H, Akarsu E, \u00d6zkaya M, \u00d6zt\u00fcrk ZA, Tutar E, Araz M. Plurihormonal pituitary adenoma: acromegaly associated with subclinical Cushing\u2019s disease. Acta Endocrinol (Buc). 2015. https:\/\/doi.org\/10.4183\/aeb.2015.389.","journal-title":"Acta Endocrinol (Buc)"},{"key":"2948_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrendo.2011.40","volume":"7","author":"S Melmed","year":"2011","unstructured":"Melmed S. Pathogenesis of pituitary tumors. Nat Rev Endocrinol. 2011;7:257\u201366.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2948_CR14","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1046\/j.1365-2559.2001.01204.x","volume":"39","author":"DM Ho","year":"2001","unstructured":"Ho DM, Hsu CY, Ting LT, Chiang H. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification. Histopathology. 2001;39(3):310\u20139.","journal-title":"Histopathology"},{"key":"2948_CR15","first-page":"63","volume":"61","author":"M Pawlikowski","year":"2010","unstructured":"Pawlikowski M, Kunert-Radek J, Radek M. Plurihormonality of pituitary adenomas in light of immunohistochemical studies. Endokrynol Pol. 2010;61:63\u20136.","journal-title":"Endokrynol Pol"},{"key":"2948_CR16","doi-asserted-by":"publisher","DOI":"10.4158\/EP12033.CR","author":"CT Luk","year":"2012","unstructured":"Luk CT, Kovacs K, Rotondo F, Horvath E, Cusimano M, Booth GL. Plurihormonal pituitary adenoma immunoreactive for thyroid-stimulating hormone, growth hormone, follicle-stimulating hormone, and prolactin. Endocr Pract. 2012. https:\/\/doi.org\/10.4158\/EP12033.CR.","journal-title":"Endocr Pract"},{"key":"2948_CR17","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/BF01411291","volume":"138","author":"A Matsuno","year":"1996","unstructured":"Matsuno A, Sasaki T, Mochizuki T, et\u00a0al. A case of Cushing\u2019s disease presenting with hypersecretion of GH and PRL five years after adrenalectomy. Acta Neurochir. 1996;138:1002.","journal-title":"Acta Neurochir"},{"key":"2948_CR18","first-page":"1540","volume":"29","author":"M BatisseLignier","year":"2012","unstructured":"BatisseLignier M, Maqdasy S, Mestre B, Roche B, Chazal J, Tauveron I. An unusual plurihormonal pituitary adenoma. Endocr Abst. 2012;29:1540.","journal-title":"Endocr Abst"},{"issue":"6","key":"2948_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/00000441-200212000-00007","volume":"324","author":"K Kageyama","year":"2002","unstructured":"Kageyama K, Nigawara T, Kamata Y, Terui K, Anzai J, Sakihara S, Suda T. A multihormonal pituitary adenoma with growth hormone and adrenocorticotropic hormone production, causing acromegaly and Cushing disease. Am J Med Sci. 2002;324(6):326\u201330.","journal-title":"Am J Med Sci"},{"issue":"1","key":"2948_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12902-017-0203-5","volume":"17","author":"T Takiguchi","year":"2017","unstructured":"Takiguchi T, Koide H, Nagano H, et\u00a0al. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing\u2019s disease: a case report. BMC Endocr Disord. 2017;17(1):54. https:\/\/doi.org\/10.1186\/s12902-017-0203-5.","journal-title":"BMC Endocr Disord"},{"issue":"4","key":"2948_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","volume":"26","author":"O Cooper","year":"2012","unstructured":"Cooper O, Melmed S. Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab. 2012;26(4):447\u201360.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2948_CR22","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2015.389","author":"H Korkmaz","year":"2015","unstructured":"Korkmaz H, Akarsu E, \u00d6zkaya M, \u00d6zt\u00fcrk ZA, Tutar E, Araz M. Plurihormonal pituitary adenoma: acromegaly associated with subclinical Cushing\u2019s disease. Acta Endo (Buc). 2015. https:\/\/doi.org\/10.4183\/aeb.2015.389.","journal-title":"Acta Endo (Buc)"},{"issue":"4","key":"2948_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4183\/aeb.2005.411","volume":"1","author":"M Dumbrava","year":"2005","unstructured":"Dumbrava M, Costinean S, Stancu C, Badiu C. \u201cMind the gap\u201d in immunohistochemical techniques used in pathology of pituitary adenomas. Acta Endo (Buc). 2005;1(4):411\u201322.","journal-title":"Acta Endo (Buc)"},{"issue":"2","key":"2948_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007;156(2):203\u201316.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2948_CR25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1046\/j.1365-2265.2003.01674.x","volume":"58","author":"KJWJ Bradley","year":"2003","unstructured":"Bradley KJWJ, Turner HE. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumors but do not recur more frequently. Clin Endocrinol (Oxf). 2003;58(1):59\u201364.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-02948-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-02948-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T23:27:25Z","timestamp":1627514845000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-02948-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2948"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-02948-6","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"assertion":[{"value":"19 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of King Fahad Medical City, RIYADH, Saudi Arabia. Our case report approval number Federal Wide Assurance NIH, USA is FWA00018774 IRB registration number with OHRP\/NIH is IRB00010471.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this paper. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}